2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$5.72+$0.10 (+1.78%)
Price as of Oct 02, 2026 5:01 PM EDT- $212.1MMarket Cap
- 339.06%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$5.72+$0.10 (+1.78%)
ANTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.62 | ||
Change | +$0.30 (+5.64%) | ||
Open | $5.29 | ||
High | $5.73 | ||
Low | $5.16 | ||
Previous Close | $5.32 | ||
Volume | 509,439 | ||
30-Day Average Volume | 250,255 | ||
1-Week Change | 14.93% | ||
1-Month Change | 2.55% | ||
1-Year Change | 339.06% | ||
3-Year Change | -65.05% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.7M | ||
Total Assets | $81.7M | ||
Market Cap | $212.1M | ||
Enterprise Value | $167.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.2M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$8.2M | ||
EBITDA | -$8.2M | ||
Net Working Capital | $74.4M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -31 | ||
PEG | -1 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/12/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue